GILD
Gilead Sciences Inc
150.60$
+0.3%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 51.2% | 65.6% | 67.5% | 45.3% | 56.3% | 49.2% | 23.4% | 21.7% | 22.9% | 25.9% | 32.5% | 31.1% | |
| 28.9% | 24.8% | 14.4% | 10.8% | 28.2% | 18.9% | 8.8% | 7.9% | 8.6% | 9.8% | 16.9% | 12.8% | |
| 33.8% | 50.6% | 56.8% | 36.3% | 47.3% | 39.5% | 10.8% | 9.6% | 10.1% | 11.7% | 19.6% | 16.3% | |
| 13.4% | 11.3% | 7.9% | 5.5% | 5.2% | 5.8% | 7.2% | 6.6% | 7.6% | 7.5% | 7.5% | 8.3% | |
| 4.0% | 3.8% | 2.8% | 1.1% | 1.3% | 1.5% | 2.5% | 2.4% | 2.4% | 2.9% | 2.9% | 3.0% | |
| 4.8% | 4.4% | 5.0% | 4.7% | 6.3% | 7.3% | 7.3% | 7.5% | 8.7% | – | – | – | |
| 3.4% | 2.3% | 2.1% | 5.9% | 6.5% | 6.7% | 11.9% | 12.3% | 13.2% | 13.4% | 14.1% | 14.1% | |
| 31.9% | 19.8% | 15.7% | 24.3% | 24.7% | 22.4% | 48.4% | 49.2% | 45.7% | 42.6% | 33.8% | 28.8% | |
| 54.4% | 63.1% | 66.0% | 70.8% | 66.2% | 63.2% | 73.4% | 69.0% | 66.4% | 63.4% | 67.4% | 61.7% | |
| 16.2% | 19.1% | 16.2% | 16.6% | 16.7% | 15.8% | 16.7% | 17.1% | 17.8% | 18.2% | 20.3% | 20.0% | |
| 0.0% | 0.0% | 2.5% | 3.9% | 4.3% | 4.1% | 4.0% | 2.2% | 3.6% | 2.9% | 3.1% | 4.8% | |
| 2.8% | 2.3% | 2.1% | 1.2% | 1.2% | 1.2% | 1.2% | 1.0% | 1.4% | 0.9% | 1.4% | 1.2% | |
| 34.4% | 40.9% | 46.2% | 43.8% | 38.6% | 35.9% | 41.9% | 37.1% | 36.3% | 37.3% | 42.2% | 37.5% | |
| 45.6% | 36.9% | 34.0% | 29.1% | 33.6% | 36.6% | 26.6% | 31.0% | 33.6% | 36.8% | 32.8% | 38.5% | |
| 36.7% | 34.7% | 31.9% | 27.1% | 29.9% | 31.5% | 21.0% | 24.0% | 24.8% | 26.2% | 19.5% | 23.3% | |
| 4.8% | 2.9% | 2.4% | 1.9% | 2.1% | 2.1% | 1.8% | 1.9% | 2.0% | 2.0% | 2.1% | 2.1% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.